Dr. Christopher Tanayan, M.D
NPI: 1083000525
Total Payments
$2,534
2024 Payments
$1,650
Companies
9
Transactions
18
Medicare Patients
573
Medicare Billing
$65,182
Payment Breakdown by Category
Other$1,500 (59.2%)
Food & Beverage$757.10 (29.9%)
Education$276.68 (10.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $1,500 | 1 | 59.2% |
| Food and Beverage | $757.10 | 15 | 29.9% |
| Education | $276.68 | 2 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Henry Schein, Inc. | $1,500 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $366.96 | 10 | $0 (2021) |
| Abbott Laboratories | $206.69 | 1 | $0 (2019) |
| BIOTRONIK INC. | $178.04 | 1 | $0 (2022) |
| Amgen Inc. | $150.00 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $69.99 | 1 | $0 (2022) |
| PFIZER INC. | $25.18 | 1 | $0 (2019) |
| GENZYME CORPORATION | $20.05 | 1 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $16.87 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,650 | 2 | Henry Schein, Inc. ($1,500) |
| 2022 | $248.03 | 2 | BIOTRONIK INC. ($178.04) |
| 2021 | $43.39 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($43.39) |
| 2020 | $95.31 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($95.31) |
| 2019 | $497.05 | 8 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($228.26) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 02/15/2024 | Henry Schein, Inc. | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,500.00 | General |
| 09/15/2022 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $178.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 05/19/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/09/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/02/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/05/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $42.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/22/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $36.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/23/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/23/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 11/13/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2019 | GENZYME CORPORATION | FABRY-DISEASE (Drug), FABRAZYME | Food and Beverage | In-kind items and services | $20.05 | General |
| 10/11/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $95.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/18/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/04/2019 | Abbott Laboratories | Ensite Cardiac Mapping System (Device) | Education | In-kind items and services | $206.69 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/22/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/16/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $97.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 504 | 614 | $312,425 | $55,810 |
| 2022 | 3 | 69 | 97 | $47,259 | $9,372 |
Total Patients
573
Total Services
711
Medicare Billing
$65,182
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 89 | 90 | $43,740 | $9,258 | 21.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 127 | $40,894 | $9,028 | 22.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 59 | $35,695 | $6,364 | 17.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 52 | $23,920 | $5,602 | 23.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 24 | 25 | $37,475 | $4,597 | 12.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 74 | 75 | $27,432 | $4,410 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 38 | $26,182 | $4,224 | 16.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 24 | $23,496 | $3,936 | 16.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $13,185 | $2,294 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $12,838 | $1,980 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 20 | $9,880 | $1,662 | 16.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $9,608 | $1,590 | 16.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 43 | $5,977 | $536.52 | 9.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 15 | 15 | $2,103 | $328.80 | 15.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 55 | $25,300 | $5,048 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 29 | $14,094 | $2,736 | 19.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $7,865 | $1,588 | 20.2% |
About Dr. Christopher Tanayan, M.D
Dr. Christopher Tanayan, M.D is a Specialist/Technologist Cardiovascular healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1083000525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Tanayan, M.D has received a total of $2,534 in payments from pharmaceutical and medical device companies, with $1,650 received in 2024. These payments were reported across 18 transactions from 9 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($1,500).
As a Medicare-enrolled provider, Tanayan has provided services to 573 Medicare beneficiaries, totaling 711 services with total Medicare billing of $65,182. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist/Technologist Cardiovascular
- Other Specialties Cardiovascular Disease
- Location New York, NY
- Active Since 04/10/2015
- Last Updated 06/05/2025
- Taxonomy Code 246X00000X
- Entity Type Individual
- NPI Number 1083000525
Products in Payments
- LifeVest (Device) $366.96
- Ensite Cardiac Mapping System (Device) $206.69
- BIOMONITOR (Device) $178.04
- Repatha (Biological) $150.00
- VYNDAQEL (Drug) $25.18
- FABRY-DISEASE (Drug) $20.05
- ANDEXXA (Biological) $16.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.